ATE450274T1 - Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen - Google Patents

Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen

Info

Publication number
ATE450274T1
ATE450274T1 AT03738319T AT03738319T ATE450274T1 AT E450274 T1 ATE450274 T1 AT E450274T1 AT 03738319 T AT03738319 T AT 03738319T AT 03738319 T AT03738319 T AT 03738319T AT E450274 T1 ATE450274 T1 AT E450274T1
Authority
AT
Austria
Prior art keywords
hydroxypropymethacrylamide
conjugates
nuclide activation
methacrylate copolymers
anticancer compounds
Prior art date
Application number
AT03738319T
Other languages
English (en)
Inventor
Bipin C Patel
Original Assignee
Psimei Pharmaceuticals Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psimei Pharmaceuticals Plc filed Critical Psimei Pharmaceuticals Plc
Application granted granted Critical
Publication of ATE450274T1 publication Critical patent/ATE450274T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)
AT03738319T 2002-07-22 2003-07-04 Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen ATE450274T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02255107 2002-07-22
PCT/GB2003/002919 WO2004009136A2 (en) 2002-07-22 2003-07-04 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds

Publications (1)

Publication Number Publication Date
ATE450274T1 true ATE450274T1 (de) 2009-12-15

Family

ID=30470320

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03738319T ATE450274T1 (de) 2002-07-22 2003-07-04 Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen

Country Status (10)

Country Link
US (1) US7662360B2 (de)
EP (1) EP1534347B1 (de)
JP (1) JP2006502993A (de)
CN (2) CN101524549A (de)
AT (1) ATE450274T1 (de)
AU (2) AU2003250391A1 (de)
CA (1) CA2493252A1 (de)
DE (1) DE60330355D1 (de)
HK (1) HK1077513A1 (de)
WO (2) WO2004009135A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1765403A4 (de) * 2004-05-10 2011-03-30 Univ Utah Res Found Kombiniertes aktives und passives targeting von biologisch aktiven wirkstoffen
EP1797427A4 (de) * 2004-09-22 2009-04-08 Odyssey Thera Inc Verfahren zur identifizierung neuer arzneimittel-leads und neuer therapeutischer verwendungen für bekannte arzneimittel
CN101265331B (zh) * 2007-03-12 2010-10-13 中国科学院化学研究所 Peg改性phpma材料及其制备方法
CA2739757C (en) * 2008-10-07 2016-07-05 Rexahn Pharmaceuticals, Inc. Hpma - docetaxel or gemcitabine conjugates and uses therefore
WO2011008863A2 (en) * 2009-07-14 2011-01-20 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for hiv disease
WO2011059779A2 (en) * 2009-10-29 2011-05-19 Lucia Irene Gonzalez Ligand-targeted multi- stereoisomer peptide polymer conjugates and uses thereof
ES2627026T3 (es) * 2011-09-05 2017-07-26 Hiroshi Maeda Sonda molecular fluorescente de tipo polímero
JP6253008B2 (ja) * 2013-08-27 2017-12-27 国立大学法人 筑波大学 高分子化ホウ素化合物及びその使用
WO2015156385A1 (ja) * 2014-04-11 2015-10-15 国立研究開発法人産業技術総合研究所 ホウ素化合物を内包および外壁に担持するカーボンナノホーン及びその製造方法
CZ308742B6 (cs) * 2015-01-14 2021-04-21 Ústav Organické Chemie A Biochemie Av Čr, V.V.I. Makromolekulární konjugáty pro izolaci, imobilizaci a vizualizaci proteinů
CZ308807B6 (cs) * 2015-01-14 2021-06-02 Ústav Organické Chemie A Biochemie Av Čr, V.V.I. Makromolekulární konjugáty pro vizualizaci a separaci proteinů a buněk
CN105503918A (zh) * 2015-12-08 2016-04-20 南京林业大学 一种含二氧杂戊硼基卟啉锌配合物及其制备方法
CN105777790B (zh) * 2016-05-17 2017-11-14 南京远淑医药科技有限公司 一种邻碳硼烷苯酚衍生物及其制备方法和应用
WO2018071767A1 (en) * 2016-10-14 2018-04-19 University Of Utah Research Foundation Antibody-polymer-drug conjugates
CN107163097B (zh) * 2017-04-20 2020-04-14 童永彭 环磷酸腺苷硼酸络合物及其制备方法,以及抗肿瘤药物和中子俘获治疗的硼剂
EP3757137B1 (de) * 2018-02-20 2022-09-07 Tokyo Institute of Technology P-borophenylalaninderivat und zusammensetzung damit und kit zur herstellung des derivats und der zusammensetzung
CN112334158B (zh) * 2018-06-20 2023-10-13 国立大学法人弘前大学 用于硼中子俘获疗法的能够在短时间内选择性地或局部地靶向肿瘤组织的聚集性硼10药剂
EP3852768A4 (de) * 2018-09-20 2022-09-14 Glyscend, Inc. Boronsäurepolymere und verwendungsverfahren
AU2020348451A1 (en) 2019-09-20 2022-04-21 Glyscend, Inc. Substituted phenyl boronic acid containing polymers and methods of use
JP2021063033A (ja) * 2019-10-11 2021-04-22 国立大学法人 東京大学 環状ペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856551A (en) * 1993-03-12 1999-01-05 The Regents Of The University Of California Macromolecular structure for boron neutron-capture therapy
US6180766B1 (en) * 1993-12-02 2001-01-30 Raymond F. Schinazi Nucleosides and oligonucleotides containing boron clusters
JPH07206690A (ja) * 1994-01-14 1995-08-08 Seitai Kagaku Kenkyusho:Kk 癌治療薬およびその中間体
US6017902A (en) * 1999-02-25 2000-01-25 Brookhaven Science Associates Boron containing amino acid compounds and methods for their use

Also Published As

Publication number Publication date
AU2003244843B2 (en) 2008-06-19
DE60330355D1 (de) 2010-01-14
CN1678353A (zh) 2005-10-05
AU2003244843A1 (en) 2004-02-09
AU2003250391A1 (en) 2004-02-09
EP1534347A2 (de) 2005-06-01
WO2004009136A3 (en) 2004-04-08
WO2004009135A3 (en) 2004-05-06
WO2004009136A2 (en) 2004-01-29
US20070258891A1 (en) 2007-11-08
JP2006502993A (ja) 2006-01-26
EP1534347B1 (de) 2009-12-02
HK1077513A1 (en) 2006-02-17
US7662360B2 (en) 2010-02-16
WO2004009135A2 (en) 2004-01-29
CN101524549A (zh) 2009-09-09
CA2493252A1 (en) 2004-01-29
AU2003250391A8 (en) 2004-02-09

Similar Documents

Publication Publication Date Title
HK1077513A1 (en) Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
ATE507845T1 (de) Polyacetal-arzneimittelkonjugate als freisetzungssystem
ATE296105T1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
DE60224296D1 (de) Haarpflegezusammensetzungen
WO2008076333A8 (en) Polymer-drug conjugates with tether groups for controlled drug delivery
DE60004172D1 (de) Gcsf konjugate
TR200003161T2 (tr) Poliol-IFN-Beta konjugatları
DE50102595D1 (de) Kosmetisches mittel
DE602005004811D1 (de) Körperpflegezusammensetzungen mit silikonen und dihydroxypropyl-trialkyl-ammoniumsalzen
ATE515290T1 (de) Körperpflegezusammensetzungen mit glycerin und hydroxypropyl-quarternär-ammoniumsalzen
WO2006060533A3 (en) Conjugates of 1, 8-bis-naphthalimides with an antibody
DE60323756D1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
TW200716151A (en) Polymeric derivative of cytidine metabolic antagonist
MXPA04004026A (es) Conjugados polimericos de inhibidores de la proteina quinasa c.
ATE538124T1 (de) Imidazokondensierte tricyclische verbindungen auf thiazoloä4,5-büpyridin-basis und pharmazeutische zusammensetzungen damit
GB2436996B8 (en) Rigid amines
MX2009006410A (es) Conjugados de polimero-oligonucleotido, proteina y/o peptido.
ATE491475T1 (de) Konjugate enthaltend gm-csf und ein polymer
TW200740781A (en) Novel compounds
BR0312850A (pt) Copolìmeros e seu uso em composições de tratamento pessoal
CY1106713T1 (el) Συνδυασμενη θεραπεια εναντιον καρκινωματων η οποια περιλαμβανει παραγωγα υποκαταστημενης ακρυλοϋλ δισταμυσινης και αλκυλιωτικους παραγοντες
WO2005027828A3 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
UA42695C2 (uk) Полімерзв'язаний антрациклін, фармацевтична композиція та проміжна сполука
WO2004014350A3 (en) Polymer conjugates of a local anaesthetic drug
ATE307579T1 (de) Pektin und ascorbinsäure enthaltende zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties